Houlihan Lokey, Inc.
NYSE:HLIFinancial - Capital Markets
-$1.78 today
- Market cap
- $9.66B
- Beta
- 0.95
- P/E (TTM)
- 22.0
- EPS (TTM)
- $6.42
- Dividend yield
- 1.77%
Volume 0.57M
Average 0.67M
HLI Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Houlihan Lokey, Inc.NYSE: HLI
Accounts Receivables · Q1 FY2027 · quarter ended Jun 2026
Accounts receivables grows in line with its trailing trend
Q1 FY2027 accounts receivables of $19M rose 32.0% year over year, in line with the +31.7% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at +29.8% a year.
Context
- Accounts receivables amounted to 3.2% of revenue in FY2026, up 2.2 pp from a year earlier.
- Accounts receivables grew in size in 1 of the last 3 fiscal years.
- FY2026 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +32.0% holds above the trailing-twelve-month pace of +31.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2026
- (82.52M) USD
- Year-over-year change
- -276.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | (82.52M) | -276.3% |
| FY2025 | 2025-03-31 | (21.93M) | +8.0% |
| FY2024 | 2024-03-31 | (23.83M) | +36.9% |
| FY2023 | 2023-03-31 | (37.74M) | -217.3% |
| FY2022 | 2022-03-31 | 32.16M | — |
Accounts Receivables vs competitors
How HLI compares with its peers on the latest reported figures
- HLI's LTM Jun 2026 accounts receivables of $77.91M is the 7th largest of the 11 companies compared; the peer median is $69.18M.
- Its year-over-year change of +31.7% is the 5th highest of 9, against a peer median of +24.0%.
- Accounts receivables amounts to 3.1% of revenue for HLI, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $13.06B | -41.0% | — | 10.1% | |
| LTM Aug 2026 | $1.83B | +37.8% | — | 14.7% | |
| LTM Jun 2026 | $421.29M | +46.6% | — | 6.3% | |
| LTM Jun 2026 | $415.91M | +941.5% | — | 19.8% | |
| LTM Jun 2026 | $143.88M | +5701.7% | +32.7% | 7.6% | |
| LTM Jun 2026 | $90.11M | -26.1% | +39.3% | 1.9% | |
| LTM Jun 2026 | $77.91M | +31.7% | +29.8% | 3.1% | |
| LTM Sep 2026 | $48.25M | +10.1% | — | 1.4% | |
| LTM Jun 2026 | $10.49M | -58.9% | +21.8% | 0.7% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding HLI) | $69.18M | +24.0% | +32.7% | 4.1% | |
Competitors are the stored peer set for HLI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 437.75M | 254.22M | 280.3M | 399.71M | 424.17M |
| Depreciation & Amortization | 48.54M | 58.22M | 28.54M | 41.27M | 42.63M |
| Deferred Income Tax | 0 | (3.45M) | 20.47M | (957K) | (25.12M) |
| Stock-Based Compensation | 91.88M | 156.94M | 166.6M | 168.44M | 201.3M |
| Change in Working Capital | 182.38M | (368.51M) | (196.37M) | 196.08M | (2.07M) |
| Accounts Receivables | 32.16M | (37.74M) | (23.83M) | (21.93M) | (82.52M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (9.96M) | (32.01M) | (23.19M) | (13.37M) | (27.9M) |
| Other Working Capital | 160.17M | (298.75M) | (149.35M) | 231.37M | 108.34M |
| Other Non-Cash Items | (23.94M) | 38.85M | 28.92M | 44.07M | 63.21M |
| Operating Cash Flow | 736.6M | 136.27M | 328.46M | 848.61M | 704.13M |
| Capital Expenditures | (8.68M) | (50.73M) | (66.73M) | (39.7M) | (22.31M) |
| Acquisitions (Net) | (361M) | (20.43M) | (3.86M) | (69.19M) | (2.54M) |
| Purchases of Investments | (101.56M) | (19.23M) | (11.28M) | (250.48M) | (263.3M) |
| Sales of Investments | 197.32M | 87.38M | 11.46M | 94.31M | 290.33M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (273.91M) | (3M) | (70.41M) | (265.06M) | 2.18M |
| Debt Repayment | (280K) | (3.03M) | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (304.79M) | (48.66M) | (24.95M) | (52.51M) | (175.43M) |
| Dividends Paid | (114.81M) | (140.38M) | (148.45M) | (165.22M) | (174.04M) |
| Other Financing Activities | (39.18M) | (48.39M) | (77.18M) | (111.34M) | (143.48M) |
| Financing Cash Flow | (459.06M) | (240.46M) | (250.59M) | (329.07M) | (492.94M) |
| Effect of Forex Changes | (16.78M) | (12.07M) | (425K) | (756K) | 4.93M |
| Net Change in Cash | (13.15M) | (119.26M) | 7.04M | 253.73M | 218.29M |
| Free Cash Flow | 727.92M | 85.54M | 261.73M | 808.91M | 681.82M |
Houlihan Lokey, Inc.
NYSE:HLI
Intrinsic Alpha fair value
Locked
Current Price
$139.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.